Status:

COMPLETED

Study of Amrubicin With or Without Cisplatin Versus Etoposide-cisplatin for Extensive Stage Small Cell Lung Cancer

Lead Sponsor:

Celgene

Conditions:

Small Cell Lung Cancer

Eligibility:

All Genders

18+ years

Phase:

PHASE2

Brief Summary

The purpose of the study is to document the activity and safety of single agent amrubicin, amrubicin combined with cisplatin, and etoposide combined with cisplatin as first-line treatment in extensive...

Eligibility Criteria

Inclusion

  • Inclusion Criteria:
  • Histologically/cytologically proven small cell lung cancer
  • Extensive disease
  • Measurable disease
  • World Health Organization (WHO) performance status 0-2
  • Age 18 years or older
  • Normal baseline cardiac function
  • No prior systemic chemotherapy for small cell lung cancer
  • Adequate organ function including bone marrow, kidney, and liver
  • No history of interstitial lung disease or pulmonary fibrosis
  • No history of prior malignancy unless patient has been disease free for greater than 5 years, or the tumour was a non-melanoma skin cancer or in-situ carcinoma of the cervix
  • No pregnancy or breast feeding; patients of child-bearing potential must agree to use an appropriate method of contraception
  • Written informed consent before randomization
  • Exclusion criteria:
  • Pre-existing peripheral neuropathy (greater than Grade 1, CTCAE version 3.0)
  • Uncontrolled or severe cardiovascular disease
  • Any psychological, familial, sociological or geographical condition potentially hampering compliance with the study protocol and follow-up schedule

Exclusion

    Key Trial Info

    Start Date :

    November 1 2006

    Trial Type :

    INTERVENTIONAL

    Allocation :

    ACTUAL

    End Date :

    December 1 2010

    Estimated Enrollment :

    99 Patients enrolled

    Trial Details

    Trial ID

    NCT00388960

    Start Date

    November 1 2006

    End Date

    December 1 2010

    Last Update

    November 19 2019

    Active Locations (25)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 7 (25 locations)

    1

    Algemeen Ziekenhuis Middelheim

    Antwerp, Belgium, 2020

    2

    Universitair Ziekenhuis Antwerpen

    Edegem, Belgium, 2650

    3

    Universiteit Gent

    Ghent, Belgium, 9000

    4

    U.Z. Gasthuisberg

    Leuven, Belgium, 3000

    Study of Amrubicin With or Without Cisplatin Versus Etoposide-cisplatin for Extensive Stage Small Cell Lung Cancer | DecenTrialz